A Phase I Clinical Trial of MEK162 in Combination With FOLFOX in Patients With Advanced Metastatic Colorectal Cancer Who Failed Prior Standard Therapy
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Binimetinib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions
- 02 Sep 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 02 Mar 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.